Pharmaceutical Companies To Pay $421 Million False Claims Act Settlement
December 10th, 2010
The U.S. Department of Justice reports that Abbott Laboratories Inc., B. Braun Medical Inc. and Boehringer Ingelheim Roxane Inc., along with affiliated entities, will pay $421 million in settlement of False Claims Act allegations. The manufacturers are charged with reporting inflated sale prices for various products in order to produce artificially high reimbursements from federal healthcare programs.
The government alleges it ultimately paid millions more in payments for these pharmaceutical products than it would have if the companies had reported accurate prices.
For more information, including an explanation of the scheme and the government’s efforts to fight fraud, see the full press release.
Entry Filed under: News
Trackback this post